首页> 外国专利> AN IN VITRO METHOD OF PREDICTING WHETHER AN OVARIAN CANCER PATIENT'S TUMOR IS RESISTANT TO A CHEMOTHERAPEUTIC DRUG

AN IN VITRO METHOD OF PREDICTING WHETHER AN OVARIAN CANCER PATIENT'S TUMOR IS RESISTANT TO A CHEMOTHERAPEUTIC DRUG

机译:预测卵巢癌患者是否抗化疗药物的体外方法

摘要

The present invention discloses an in vitro method of predicting whether an ovarian cancer patient's tumor is resistant to a chemotherapeutic drug comprising the steps of (a) measuring a gene expression level of S100A11 in: (i) an ovarian cancer tumor sample taken from the patient, and (ii) a chemotherapeutic drug responsive ovarian tumor sample; (b) comparing the expression level of said gene in the ovarian cancer tumor sample taken from the patient and the chemotherapeutic drug responsive ovarian tumor sample; and (c) determining that the ovarian cancer patient's tumor is resistant to the chemotherapeutic drug when the expression level of said gene in the ovarian cancer tumor sample taken from the patient is at least 1.2-fold greater than the expression level of said gene in the chemotherapeutic drug responsive ovarian tumor sample.
机译:本发明公开了一种预测卵巢癌患者的肿瘤是否对化学治疗药物具有抗性的体外方法,该方法包括以下步骤:(a)测量以下患者的S100A11的基因表达水平:(i)取自患者的卵巢癌肿瘤样品,以及(ii)化疗药物反应性卵巢肿瘤样品; (b)比较所述基因在取自患者的卵巢癌肿瘤样品和对化疗药物有反应的卵巢肿瘤样品中的表达水平; (c)当取自患者的卵巢癌肿瘤样品中所述基因的表达水平比所述基因在卵巢癌中的表达水平高至少1.2倍时,确定卵巢癌患者的肿瘤对化疗药物具有抗性。化疗药物反应性卵巢肿瘤样品。

著录项

  • 公开/公告号IN2011KN00034A

    专利类型

  • 公开/公告日2016-09-02

    原文格式PDF

  • 申请/专利权人

    申请/专利号IN34/KOLNP/2011

  • 发明设计人 AL MURRANI SAMER;

    申请日2011-01-04

  • 分类号A61K48/00;

  • 国家 IN

  • 入库时间 2022-08-21 14:25:52

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号